Site de l’association HerPAs

publication scientifiques de 2014


Epstein-barr virus late gene trans­crip­tion depends on the assem­bly of a virus-spe­ci­fic prei­ni­tia­tion com­plex. Aubry V, Mure F, Mariamé B, Deschamps T, Wyrwicz LS, Manet E, Gruffat H. J Virol. 2014 Nov ;88(21):12825-38. doi : 10.1128/JVI.02139-14.

Pro-apop­to­tic meio­gy­nin A deri­va­ti­ves that target Bcl-xL and Mcl-1. Desrat S, Pujals A, Colas C, Dardenne J, Gény C, Favre L, Dumontet V, Iorga BI, Litaudon M, Raphaël M, Wiels J, Roussi F. Bioorg Med Chem Lett. 2014 Nov 1 ;24(21):5086-8. doi : 10.1016/j.bmcl.2014.09.004

Perinucleolar relo­ca­li­za­tion and nucleo­lin as cru­cial events in the trans­crip­tio­nal acti­va­tion of key genes in mantle cell lym­phoma. Allinne J, Pichugin A, Iarovaia O, Klibi M, Barat A, Zlotek-Zlotkiewicz E, Markozashvili D, Petrova N, Camara-Clayette V, Ioudinkova E, Wiels J, Razin SV, Ribrag V, Lipinski M, Vassetzky YS. Blood. 2014 Mar 27 ;123(13):2044-53. doi : 10.1182/blood-2013-06-510511.

Epstein-Barr virus nuclear anti­gen 3A pro­tein regu­la­tes CDKN2B trans­crip­tion via inte­rac­tion with MIZ-1.. Bazot Q, Deschamps T, Tafforeau L, Siouda M, Leblanc P, Harth-Hertle ML, Rabourdin-Combe C, Lotteau V, Kempkes B, Tommasino M, Gruffat H, Manet E. Nucleic Acids Res. 2014 Sep ;42(15):9700-16. doi : 10.1093/nar/gku697. _Epstein-Barr virus down-regu­la­tes tumor sup­pres­sor DOK1 expres­sion.Siouda M, Frecha C, Accardi R, Yue J, Cuenin C, Gruffat H, Manet E, Herceg Z, Sylla BS, Tommasino M. PLoS Pathog. 2014 May 8 ;10(5):e1004125. doi : 10.1371/jour­nal.ppat.1004125. eCol­lec­tion 2014 May.

TLR9 trans­crip­tio­nal regu­la­tion in res­ponse to double-stran­ded DNA viru­ses.. Zannetti C, Parroche P, Panaye M, Roblot G, Gruffat H, Manet E, Debaud AL, Plumas J, Vey N, Caux C, Bendriss-Vermare N, Hasan UA. J Immunol. 2014 Oct 1 ;193(7):3398-408. doi : 10.4049/jim­mu­nol.1400249.

Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient In Vivo Reactivation.. Ramakrishna C., Ferraioli A., Callé A., Openshaw H., Lundberg P. S., Lomonte P., and Cantin E.M. PLoS Pathogens. Positive revi­sion. (IF : 8.1)

Expression of the epi­der­mo­dys­pla­sia ver­ru­ci­for­mis-asso­cia­ted genes EVER1 and EVER2 is acti­va­ted by exo­ge­nous DNA and inhi­bi­ted by LMP1 onco­pro­tein from Epstein-Barr virus.. Frecha C., Chevalier S., van Uden P., Rubio I., Siouda M., Saidj D., Cohen C., Lomonte P., Accardi R., and Tommasino M. J Virol. 2015 Jan 15 ;89(2):1461-7. doi : 10.1128/JVI.02936-14. (IF : 4.7)

Cavallero S., Huot N., Francelle L., Lomonte P., Naas T., Labetoulle M. 2014. Biological fea­tu­res of herpes sim­plex virus type 1 latency in mice accor­ding to expe­ri­men­tal condi­tions and type of neu­ro­nes.. Cavallero S., Huot N., Francelle L., Lomonte P., Naas T., Labetoulle M. Invest Ophthalmol Vis Sci. 14-14673. (IF : 3.6)

PML nuclear bodies, cen­tro­me­res, and the control of herpes sim­plex virus 1 latency (review in French). Lomonte P. 2014. Virologie, 18 (3), 170-179. (IF : 0.1)

Detection of the genome and trans­cripts of a per­sis­tent DNA virus in neu­ro­nal tis­sues by fluo­res­cent in situ hybri­di­za­tion com­bi­ned to immuno-stai­ning.. Catez F., Rousseau A., Labetoulle M., and Lomonte P. 2014. Journal of Visualized Experiment, JoVE, (83), e51091.

miR-31 is consis­tently inac­ti­va­ted in EBV-asso­cia­ted naso­pha­ryn­geal car­ci­noma and contri­bu­tes to its tumo­ri­ge­ne­sis.. Cheung CC, Chung GT, Lun SW, To KF, Choy KW, Lau KM, Siu SP, Guan XY, Ngan RK, Yip TT, Busson P, Tsao SW, Lo KW. Mol Cancer. 2014 Aug 7 ;13:184. doi : 10.1186/1476-4598-13-184.

Expression of two paren­tal imprin­ted miRNAs impro­ves the risk-stra­ti­fi­ca­tion of neu­ro­blas­toma patients. Gattolliat C.H., Le Teuff G., Combaret V., Mussard E., Valteau-Couanet D. , Busson P., Bénard J., Douc-Rasy S. Cancer Medicine 3 : 998-1009 (2014).

Treatment of naso­pha­ryn­geal car­ci­noma cells with the his­tone-dea­ce­ty­lase inhi­bi­tor abexi­no­stat : coo­pe­ra­tive effects with cis-platin and radio­the­rapy on patient-deri­ved xeno­grafts.. Gressette M, Vérillaud B, Jimenez-Pailhès AS, Lelièvre H, Lo KW, Ferrand FR, Gattolliat CH, Jacquet-Bescond A, Kraus-Berthier L, Depil S, Busson P. PLoS One. 2014 Mar 11 ;9(3):e91325. doi : 10.1371/jour­nal.pone.0091325.

Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, Diluca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Hollsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. Classification of HHV-6A and HHV-6B as dis­tinct viru­ses. Arch Virol 2014 ;159:863-70.

Amiel C, Schneider V, Guessant S, Hamidi M, Kherallah K, Lebrette MG, Chas J, Lependeven C, Pialoux G. Initiation of ril­pi­vi­rine, teno­fo­vir and emtri­ci­ta­bine (RPV/TDF/FTC) regi­men in 363 patients with viro­lo­gi­cal vigi­lance assess­ment in ’real life’. J Antimicrob Chemother 2014 (sous presse).

Bieber T, Chosidow O, Bodsworth N, Tyring S, Hercogova J, Bloch M, Davis M, Lewis M, Boutolleau D, Attali P. Efficacy and safety of aci­clo­vir muco­adhe­sive buccal tablet in immu­no­com­pe­tent patients with labial herpes (LIP Trial) : a double-blind, pla­cebo-control­led, self-ini­tia­ted trial. J Drugs Dermatol 2014 ;13:791-8.

Boizeau L, Laperche S, Desire N, Jourdain C, Thibault V, Servant-Delmas A. Could dro­plet digi­tal PCR be used ins­tead of real-time PCR for quan­ti­ta­tive detec­tion of Hepatitis B virus genome in plasma ? J Clin Microbiol 2014 (sous presse).

Bottero J, Boyd A, Lemoine M, Carrat F, Gozlan J, Collignon A, Boo N, Dhotte P, Varsat B, Muller G, Cha O, Valin N, Nau J, Campa P, Silbermann B, Bary M, Girard PM, Lacombe K. Current state of and needs for hepa­ti­tis B scree­ning : results of a large scree­ning study in a low-pre­va­lent, metro­po­li­tan region. PLoS One 2014 ;9:e92266.

Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K. Persistent vire­mia in HIV-hepa­ti­tis B co-infec­ted patients under­going long-term teno­fo­vir : viro­lo­gi­cal and cli­ni­cal impli­ca­tions. Hepatology 2014.

Burrel S, Rouard C, Boutolleau D. Helicase-pri­mase inhi­bi­tor pri­te­li­vir for HSV-2 infec­tion. N Engl J Med 2014 ;370:1663-4.

Cufi P, Soussan P, Truffault F, Fetouchi R, Robinet M, Fadel E, Berrih-Aknin S, Le Panse R. Thymoma-asso­cia­ted myas­the­nia gravis : On the search for a patho­gen signa­ture. J autoim­mun 2014 ;52:29-35.

Godet AN, Soignon G, Koubi H, Bonnafous P, Agut H, Poirot C, Gautheret-Dejean A. Presence of HHV-6 genome in sper­ma­to­zoa in a context of cou­ples with low fer­ti­lity : what type of infec­tion ? Andrologia 2014 (sous presse).

Guerrera IC, Quetier I, Fetouchi R, Moreau F, Vauloup-Fellous C, Lekbaby B, Rousselot C, Chhuon C, Edelman A, Lefevre M, Nicolas JC, Kremsdorf D, Lacau Saint Guily J, Soussan P. Regulation of inter­leu­kin-6 in head and neck squa­mous cell car­ci­noma is rela­ted to papil­lo­ma­vi­rus infec­tion. J Proteome Res2014 ;13:1002-11.

Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadiere B, van der Werf S, Autran B, Carcelain G. Low Titers of Serum Antibodies Inhibiting Hemagglutination Predict Fatal Fulminant Influenza A(H1N1) 2009 Infection. Am J Respir Crit Care Med2014 ;189:1240-9.

Matheus S, Pham TB, Labeau B, Huong VT, Lacoste V, Deparis X, Marechal V. Kinetics of dengue non-struc­tu­ral pro­tein 1 anti­gen and IgM and IgA anti­bo­dies in capil­lary blood sam­ples from confir­med dengue patients. Am J Trop Med Hyg 2014 ;90:438-43.

Pedergnana V, Syx L, Cobat A, Guergnon J, Brice P, Ferme C, Carde P, Hermine O, Pendeven CL, Amiel C, Taoufik Y, Alcais A, Theodorou I, Besson C, Abel L. Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens. PLoS One 2014 ;9:e102501.

Saadoun D, Resche Rigon M, Thibault V, Longuet M, Pol S, Blanc F, Pialoux G, Karras A, Bazin-Karra D, Cazorla C, Vittecoq D, Musset L, Decaux O, Ziza JM, Lambotte O, Cacoub P. Peg-IFNalpha/riba­vi­rin/pro­tease inhi­bi­tor com­bi­na­tion in hepa­ti­tis C virus asso­cia­ted mixed cryo­glo­bu­li­ne­mia vas­cu­li­tis : results at week 24. Ann Rheum Dis 2014 ;73:831-7.

Seang S, Boutolleau D, Burrel S, Regnier S, Epelboin L, Voujon D, Valantin MA, Katlama C, Agut H, Caumes E. Long-term follow-up of HIV-infec­ted patients once diag­no­sed with acy­clo­vir-resis­tant herpes sim­plex virus infec­tion. Int J STD AIDS 2014 ;25:676-82.